Vice President, Head of Formulation Development
WuXi STA, a subsidiary of WuXi AppTec
San Diego, California
Dr. Santipharp Panmai is the Vice President and the head of formulation development at WuXi STA, a subsidiary of WuXi AppTec since 2017. He leads formulation teams in Shanghai and Wuxi, China, responsible for formulation development and clinical trial materials of new chemical entities from global clients (US, Europe, and Asia).Before joining WuXi STA, he worked at MSD in the US (PA/NJ) for 18 years in the Pharmaceutical Sciences group. He has extensive experience in formulation development and material characterization.
Overcoming the Unique Challenges in Today’s Early Stage Drug Development
Wednesday, October 25, 2023
9:00 AM – 10:00 AM ET